Current and future influenza vaccines
- PMID: 30692696
- DOI: 10.1038/s41591-018-0340-z
Current and future influenza vaccines
Abstract
Although antiviral drugs and vaccines have reduced the economic and healthcare burdens of influenza, influenza epidemics continue to take a toll. Over the past decade, research on influenza viruses has revealed a potential path to improvement. The clues have come from accumulated discoveries from basic and clinical studies. Now, virus surveillance allows researchers to monitor influenza virus epidemic trends and to accumulate virus sequences in public databases, which leads to better selection of candidate viruses for vaccines and early detection of drug-resistant viruses. Here we provide an overview of current vaccine options and describe efforts directed toward the development of next-generation vaccines. Finally, we propose a plan for the development of an optimal influenza vaccine.
Similar articles
-
The evolution of seasonal influenza viruses.Nat Rev Microbiol. 2018 Jan;16(1):47-60. doi: 10.1038/nrmicro.2017.118. Epub 2017 Oct 30. Nat Rev Microbiol. 2018. PMID: 29081496 Review.
-
New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.Vaccine. 2013 Apr 17;31 Suppl 1:A1-20. doi: 10.1016/j.vaccine.2013.02.033. Vaccine. 2013. PMID: 23587330
-
H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?Expert Rev Vaccines. 2014 Jan;13(1):1-4. doi: 10.1586/14760584.2014.864564. Epub 2013 Nov 28. Expert Rev Vaccines. 2014. PMID: 24308582
-
[Influenza surveillance].Postepy Hig Med Dosw (Online). 2016 Apr 18;70:313-8. doi: 10.5604/17322693.1199709. Postepy Hig Med Dosw (Online). 2016. PMID: 27117107 Review. Polish.
-
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.Wkly Epidemiol Rec. 2015 Oct 16;90(42):561-71. Wkly Epidemiol Rec. 2015. PMID: 26477059 English, French. No abstract available.
Cited by
-
Unlocking influenza B: exploring molecular biology and reverse genetics for epidemic control and vaccine innovation.Virol J. 2024 Aug 23;21(1):196. doi: 10.1186/s12985-024-02433-8. Virol J. 2024. PMID: 39180083 Free PMC article. Review.
-
Flublok Quadrivalent Vaccine Adjuvanted with R-DOTAP Elicits a Robust and Multifunctional CD4 T Cell Response That Is of Greater Magnitude and Functional Diversity Than Conventional Adjuvant Systems.Vaccines (Basel). 2024 Mar 7;12(3):281. doi: 10.3390/vaccines12030281. Vaccines (Basel). 2024. PMID: 38543915 Free PMC article.
-
Altering Intracellular Localization of the RNA Interference Factors by Influenza A Virus Non-structural Protein 1.Front Microbiol. 2020 Nov 12;11:590904. doi: 10.3389/fmicb.2020.590904. eCollection 2020. Front Microbiol. 2020. PMID: 33281788 Free PMC article.
-
Influenza-Specific Lung-Resident Memory CD8+ T Cells.Cold Spring Harb Perspect Biol. 2021 Feb 1;13(2):a037978. doi: 10.1101/cshperspect.a037978. Cold Spring Harb Perspect Biol. 2021. PMID: 33288540 Free PMC article. Review.
-
Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity.Vaccines (Basel). 2021 Jan 21;9(2):75. doi: 10.3390/vaccines9020075. Vaccines (Basel). 2021. PMID: 33494477 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous